A longitudinal analysis of the effect of nonmedical exemption law and vaccine uptake on vaccine-targeted disease rates

American Journal of Public Health

Volumn 104, Issue 2, 2014, Pages 371-377

  Yang, Y Tony ^a   Debold, Vicky ^a  

^a GEORGE MASON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAEMOPHILUS VACCINE; VIRUS VACCINE;

ARTICLE; GOVERNMENT; GOVERNMENT REGULATION; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; HEPATITIS B; HUMAN; INCIDENCE; MEASLES; MUMPS; PERTUSSIS; VIRUS INFECTION;

GOVERNMENT REGULATION; HAEMOPHILUS INFECTIONS; HAEMOPHILUS INFLUENZAE TYPE B; HAEMOPHILUS VACCINES; HEPATITIS B; HUMANS; INCIDENCE; MEASLES; MUMPS; STATE GOVERNMENT; VIRAL VACCINES; VIRUS DISEASES; WHOOPING COUGH;

EID: 84893387929     PISSN: 00900036     EISSN: 15410048     Source Type: Journal    
DOI: 10.2105/AJPH.2013.301538     Document Type: Article

References (46)

1. Centers for Disease Control and Prevention. National, state, and local area vaccination coverage among children aged 19-35 months-United States, 2009. MMWR Morb Mortal Wkly Rep. 2010;59(36): 1171-1177.
2. Centers for Disease Control and Prevention. Pertussis epidemic-Washington, 2012. MMWR Morb Mortal Wkly Rep. 2012;61(28):517-522.
3. Centers for Disease Control and Prevention. Measles-United States, 2011. MMWR Morb Mortal Wkly Rep. 2012;61(15):253-257.
4. Barskey AE, Schulte C, Rosen JB, et al. Mumps outbreak in Orthodox Jewish communities in the United States. N Engl J Med. 2012;367(18):1704-1713.
5. Jacobson v. Commonwealth of Massachusetts, 197 U.S. 11 (1905).
6. Salmon DA, Sapsin JW, Teret S, et al. Public health and the politics of school immunization requirements. Am J Public Health. 2005;95(5):778-783.
7. Stadlin S, Bednarczyk RA, Omer SB. Medical exemptions to school immunization requirements in the United States-association of state policies with medical exemption rates (2004-2011). J Infect Dis. 2012; 206(7):989-992.
8. Centers for Disease Control and Prevention. Childcare and school vaccination requirements, 2007-2008. Available at: Http://www2a.cdc.gov/nip/ schoolsurv/CombinedLaws2007.pdf. Accessed April 22, 2013.
9. Omer SB, Pan WK, Halsey NA, et al. Nonmedical exemptions to school immunization requirements: Secular trends and association of state policies with pertussis incidence. JAMA. 2006;296(14):1757-1763.
10. Averhoff F, Linton L, Peddecord KM, Edwards C, Wang W, Fishbein D. A middle school immunization law rapidly and substantially increases immunization coverage among adolescents. Am J Public Health. 2004; 94(6):978-984.
11. Kharbanda EO, Stockwell MS, Colgrove J, Natarajan K, Rickert VI. Changes in Tdap and MCV4 vaccine coverage following enactment of a statewide requirement of Tdap vaccination for entry into sixth grade. Am J Public Health. 2010;100(9):1635-1640.
12. Bugenske E, Stokley S, Kennedy A, Dorell C. Middle school vaccination requirements and adolescent vaccination coverage. Pediatrics. 2012;129(6):1056-1063.
13. Roush SW, Murphy TV; Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007;298(18): 2155-2163.
14. Centers for Disease Control and Prevention. Invasive Haemophilus influenzae type B disease in five young children-Minnesota, 2008. MMWR Morb Mortal Wkly Rep. 2009;58(3):58-60.
15. Salmon DA, Moulton LH, Omer SB, DeHart MP, Stokley S, Halsey NA. Factors associated with refusal of childhood vaccines among parents of school-aged children: A case-control study. Arch Pediatr Adolesc Med. 2005;159(5):470-476.
16. Salmon DA, Sotir MJ, Pan WK, et al. Parental vaccine refusal in Wisconsin: A case-control study. Wis Med J. 2009;108(1):17-23.
17. Centers for Disease Control and Prevention. School vaccination coverage reports. Available at: Http://www2. cdc.gov/nip/schoolsurv/report.asp. Accessed April 22, 2013.
18. Debold V, Yang YT. Evaluating the Restrictiveness of State Vaccine Exemption Laws. George Mason University Working Paper. 2013.
19. Viera AJ, Garrett JM. Understanding interobserver agreement: The kappa statistic. Fam Med. 2005;37 (5):360-363.
20. Siegel C, Davidson A, Kafadar K, Norris JM, Todd J, Steiner J. Geographic analysis of pertussis infection in an urban area: A tool for health services planning. Am J Public Health. 1997;87(12):2022-2026.
21. Danis K, Georgakopoulou T, Stavrou T, Laggas D, Panagiotopoulos T. Socioeconomic factors play a more important role in childhood vaccination coverage than parental perceptions: A cross-sectional study in Greece. Vaccine. 2010;28(7):1861-1869.
22. Smith PJ, Chu SY, Barker LE. Children who have received no vaccines: Who are they and where do they live? Pediatrics. 2004;114(1):187-195.
23. Schulte JM, Atkinson WL, Suarez L, et al. Use of Texas birth certificate data to predict measles immunization status. South Med J. 1996;89(8):793-797.
24. Luman ET, Barker LE, Simpson DM, Rodewald LE, Szilagyi PG, Zhao Z. National, state and urban-area vaccination-coverage levels among children aged 19-35 months, United States, 1999. Am J Prev Med. 2001; 20(4 suppl):88-153.
25. Parker Fiebelkorn A, Redd SB, Gallagher K, et al. Measles in the United States during the postelimination era. J Infect Dis. 2010;202(10):1520-1528.
26. Fielding JE, CumberlandWG, Pettitt L. Immunization status of children of employees in a large corporation. JAMA. 1994;271(7):525-530.
27. Brown KF, Kroll JS, Hudson MJ, et al. Factors underlying parental decisions about combination childhood vaccinations including MMR: A systematic review. Vaccine. 2010;28(26):4235-4248.
28. Nagaoka K, Fujiwara T, Ito J. Do income inequality and social capital associate with measles-containing vaccine coverage rate? Vaccine. 2012;30(52):7481-7488.
29. Centers for Disease Control and Prevention. Pertussis, surveillance, and reporting. Available at: Http://www.cdc.gov/pertussis/surv-reporting.html. Accessed November 5, 2012.
30. Salmon DA, Haber M, Gangarosa EJ, Phillips L, Smith NJ, Chen RT. Health consequences of religious and philosophical exemptions from immunization laws: Individual and societal risk of measles. JAMA. 1999; 282(1):47-53.
31. Feikin DR, Lezotte DC, Hamman RF, Salman DA, Chen RT, Hoffman RE. Individual and community risks of measles and pertussis associated with personal exemptions to immunization. JAMA. 2000;284(24): 3145-3150.
32. Rota JS, Salmon DA, Rodewald LE, Chen RT, Hibbs BF, Gangarosa EJ. Processes for obtaining nonmedical exemptions to state immunization laws. Am J Public Health. 2001;91(4):645-648.
33. Immunization Action Coalition. State information, Tdap booster requirements for secondary schools. Available at: Http://www.immunize.org/laws/ tdap.asp. Accessed April 22, 2013.
34. Centers for Disease Control and Prevention. School vaccination coverage reports, coverage estimates for school entry vaccinations, pertussis 2007-2008. Available at: Http://www2.cdc.gov/nip/schoolsurv/nationalDetail8.asp?v= Pertussis&y=2008. Accessed April 22, 2013.
35. Washington State Legislature. RCW 28A.210.090. Immunization program-exemptions. Available at: Http://apps.leg.wa.gov/RCW/default.aspx?cite= 28A.210.090. Accessed April 22, 2013.
36. Centers for Disease Control and Prevention. Vaccination coverage among children in kindergarten-United States, 2009-10 school year. MMWR Morb Mortal Wkly Rep. 2011;60(21):700-704.
37. Centers for Disease Control and Prevention. Vaccination coverage among children in kindergarten-United States, 2011-12 school year. MMWR Morb Mortal Wkly Rep. 2012;61(33):647-652.
38. Misegades LK, Winter K, Harriman K, et al. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA. 2012;308(20): 2126-2132.
39. Klein NP, Bartlett J, Rowhani-Rahbar A, Fireman B, Baxter R. Waning protection after fifth dose of acellular pertussis vaccine in children. N Engl J Med. 2012;367 (11):1012-1019.
40. Roush SW. Surveillance indicators. In: Manual for the Surveillance of Vaccine-Preventable Diseases. 5th ed. Atlanta, GA: Centers for Disease Control and Prevention; 2011.
41. Roush SW. National surveillance of vaccinepreventable diseases. In: Manual for the Surveillance of Vaccine-Preventable Diseases. 5th ed. Atlanta, GA: Centers for Disease Control and Prevention; 2011.
42. Cherry JD. Pertussis vaccines for adolescents and adults. Pediatrics. 2005;116(3):755-756.
43. Marconi GP, Ross LA, Nager AL. An upsurge in pertussis: Epidemiology and trends. Pediatr Emerg Care. 2012;28(3):215-219.
44. Health Resources and Services Administration, National Vaccine Injury Compensation Program. Data and statistics, statistics report. 2013. Available at: Http://www.hrsa.gov/vaccinecompensation/statisticsreports. html#Stats. Accessed April 22, 2013.
45. Institute of Medicine. Adverse Effects of Vaccines: Evidence and Causality. Washington, DC: National Academies Press; 2012.
46. Institute of Medicine. Adverse Events Associated With Childhood Vaccines: Evidence Bearing on Causality. Washington, DC: National Academies Press; 1994.